MARINUS PHARMACEUTICALS, INC. Contract with Customer, Asset, after Allowance for Credit Loss
MARINUS PHARMACEUTICALS, INC. had Contract with Customer, Asset, after Allowance for Credit Loss of $5.62 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2022-11-07
- 2022-09-30: Contract with Customer, Asset, after Allowance for Credit Loss $5.62M.
- 2022-06-30: Contract with Customer, Asset, after Allowance for Credit Loss $6.11M.
- 2022-03-31: Contract with Customer, Asset, after Allowance for Credit Loss $6.63M.
- 2021-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $7.18M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2022-09-30 | $5.62M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $6.11M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $6.63M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $7.18M 10-Q · filed 2022-11-07 |